Viewing Study NCT04769895


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2025-12-25 @ 1:00 PM
Study NCT ID: NCT04769895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-17
First Post: 2021-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
Sponsor: MaaT Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module